Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 12/20 | 0.71 |
| ▸ | RAF1 | P04049 | 10/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | BRAF | P15056 | 2/20 | 0.67 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.67 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MIF | P14174 | 1/20 | 0.49 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30615225 | 1.00 | MAP2K1 (0.71) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL29842959 | 0.89 | MAP2K1 (0.71) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL965293 | 0.89 | MAP2K1 (0.71) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL26997739 | 0.87 | MAP2K1 (0.77) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL960480 | 0.85 | MAP2K1 (0.67) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL29425523 | 0.85 | MAP2K1 (0.67) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL959547 | 0.85 | MAP2K1 (0.72) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL959413 | 0.84 | MAP2K1 (0.69) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL12694075 | 0.84 | MAP2K1 (0.82) | MAP2K1RAF1CYP2C9CYP3A4BRAF | |
| SCHEMBL962160 | 0.83 | MAP2K1 (0.85) | MAP2K1RAF1CYP2C9CYP3A4BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289811-A1 | HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS | NESTED THERAPEUTICS, INC. | 2025-09-18 | — | — | US | disclosed |
| WO-2023211812-A1 | HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS | NESTED THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289811-A1 | HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS | MAPK1, MAP3K1, MAPK3 | MAP2K1 44/4885RAF1 42/4885CYP2C9 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.